Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Kehne

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
CNS & Neurological Disorders Drug Targets|May 22, 2007
The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disordersJohn H Kehne
CNS & Neurological Disorders Drug Targets|April 14, 2007
DepressionRonald S Duman, John H Kehne
CNS & Neurological Disorders Drug Targets|May 22, 2007
DepressionRonald S Duman, John H Kehne
Pharmacology & Therapeutics|September 10, 2010
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsJohn H Kehne, Christopher K Cain
Current Topics in Medicinal Chemistry|August 12, 2008
D2 receptor partial agonists: treatment of CNS disorders of dopamine functionJohn H Kehne, Terrance H Andree, Julia N Heinrich
Expert Opinion on Investigational Drugs|July 28, 2012
Targeting memory processes with drugs to prevent or cure PTSDChristopher K Cain, George D Maynard, John H Kehne
Neurochemical Research|May 3, 2017
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)John H Kehne, Brian D Klein, Shamsi Raeissi, et al.
Psychopharmacology|November 25, 2010
Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervalsJames K Rowlett, John H Kehne, Ken J Sprenger, et al.
Journal of Sleep Research|August 18, 2009
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humansPeter T Morgan, John H Kehne, Ken J Sprenger, et al.
Journal of Clinical Pharmacology|February 26, 2013
The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteersMichael J Avram, Daniel A Spyker, John H Kehne, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|May 22, 2007
The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disordersJohn H Kehne
CNS & Neurological Disorders Drug Targets|April 14, 2007
DepressionRonald S Duman, John H Kehne
CNS & Neurological Disorders Drug Targets|May 22, 2007
DepressionRonald S Duman, John H Kehne
Pharmacology & Therapeutics|September 10, 2010
Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsJohn H Kehne, Christopher K Cain
Current Topics in Medicinal Chemistry|August 12, 2008
D2 receptor partial agonists: treatment of CNS disorders of dopamine functionJohn H Kehne, Terrance H Andree, Julia N Heinrich
Expert Opinion on Investigational Drugs|July 28, 2012
Targeting memory processes with drugs to prevent or cure PTSDChristopher K Cain, George D Maynard, John H Kehne
Neurochemical Research|May 3, 2017
The National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program (ETSP)John H Kehne, Brian D Klein, Shamsi Raeissi, et al.
Psychopharmacology|November 25, 2010
Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervalsJames K Rowlett, John H Kehne, Ken J Sprenger, et al.
Journal of Sleep Research|August 18, 2009
Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humansPeter T Morgan, John H Kehne, Ken J Sprenger, et al.
Journal of Clinical Pharmacology|February 26, 2013
The pharmacokinetics and pharmacodynamics of zaleplon delivered as a thermally generated aerosol in a single breath to volunteersMichael J Avram, Daniel A Spyker, John H Kehne, et al.
Pageof 2